In the case of adoptive Treg therapy, clinicians fear an increased risk of infectious complications caused by herpes virus reactivation or opportunistic pathogens [4]. As mentioned earlier, the first clinical trials applying Treg therapy did not, at first, observe an increased infection risk [14...